Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of NaPPS in Healthy Adult Males
jRCT2031250218Phase 1Completed
- Sponsor
- ReqMed Company, Ltd.
- Start
- May 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label trial of pentosan polysulfate sodium (2 arms), sponsored by ReqMed Company, Ltd. Primary endpoints: Plasma AUC and Plasma Cmax. Started May 2025; status: completed.
02
Drugs
pentosan polysulfate sodium
Beyond the preview
Go deeper on jRCT2031250218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250218.